Cargando…

Drugs Affecting Growth of Tumours

During recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for an expanding number of tumour types and stages, while many new agents are being investigated when standard therapy is lacking or failing. Apar...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Pinedo, Herbert M. (Editor ), Smorenburg, Carolien H. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Basel : Birkhäuser Basel : Imprint: Birkhäuser, 2006.
Edición:1st ed. 2006.
Colección:Milestones in Drug Therapy,
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-7643-7407-5
003 DE-He213
005 20220115175640.0
007 cr nn 008mamaa
008 100301s2006 sz | s |||| 0|eng d
020 |a 9783764374075  |9 978-3-7643-7407-5 
024 7 |a 10.1007/3-7643-7407-1  |2 doi 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Drugs Affecting Growth of Tumours  |h [electronic resource] /  |c edited by Herbert M. Pinedo, Carolien H. Smorenburg. 
250 |a 1st ed. 2006. 
264 1 |a Basel :  |b Birkhäuser Basel :  |b Imprint: Birkhäuser,  |c 2006. 
300 |a IX, 238 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Milestones in Drug Therapy,  |x 2296-6064 
505 0 |a Antimetabolites -- DNA-intercalators - the anthracyclines -- Topoisomerase inhibitors -- Tubulin interacting agents -- Vaccination therapies in solid tumors -- Oral anticancer agents -- Anti-angiogenesis agents -- Signal transduction inhibitors -- Endocrine therapy of breast cancer. 
520 |a During recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for an expanding number of tumour types and stages, while many new agents are being investigated when standard therapy is lacking or failing. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds. This topical volume provides an up-to-date overview of clinically relevant data on anticancer agents, and is not only intended for those working as a medical doctor with cancer patients, but also for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics. 
650 0 |a Oncology. 
650 0 |a Pharmacology. 
650 0 |a Cancer. 
650 0 |a Immunology. 
650 0 |a Cytology. 
650 1 4 |a Oncology. 
650 2 4 |a Pharmacology. 
650 2 4 |a Cancer Biology. 
650 2 4 |a Immunology. 
650 2 4 |a Cell Biology. 
700 1 |a Pinedo, Herbert M.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Smorenburg, Carolien H.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783764390044 
776 0 8 |i Printed edition:  |z 9783764321963 
830 0 |a Milestones in Drug Therapy,  |x 2296-6064 
856 4 0 |u https://doi.uam.elogim.com/10.1007/3-7643-7407-1  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)